• MabSpace granted FDA Approval for MSB2311 IND biospectrumasia
    March 01, 2018
    MabSpace Biosciences Announces FDA Approval of IND for MSB2311, a Second Generation PD-L1 Antibody With pH Dependent Antigen Binding and Recycling Property
PharmaSources Customer Service